drugset / Trial / NCT06422000

Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis

NCT06422000

Phase 3 Completed 75 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the effectiveness of pentoxifylline versus probiotics supplementation as adjuvant therapy for preterm neonates with necrotizing enterocolitis.

Timeline

Start
2022-06-30
Primary completion
2023-11-01
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentoxifylline Small molecule 30 mg/kg Intravenous
Comparator Probio Tec BB12-Blend 30- IF Other / unclassified 100 mg Other